インスリンポンプ市場：製品、適応疾患、付属品、流通チャネル別-2025～2030年の世界予測

インスリンポンプ市場は、2023年に81億9,000万米ドルと評価され、2024年には90億8,000万米ドルに達すると予測され、CAGR 10.97％で成長し、2030年には169億9,000万米ドルに達すると予測されています。

インスリンポンプ市場は、糖尿病管理産業において不可欠なセグメントであり、患者が血糖コントロールを維持できるよう、持続的な皮下インスリン注入に焦点を当てています。その必要性は、ライフスタイルの変化、肥満、遺伝的要因によって世界中で糖尿病の有病率が増加していることから生じています。主要用途は1型糖尿病の管理で、従来のインスリン投与法では不十分な2型糖尿病での使用例も増えています。最終用途の範囲には主に病院、専門クリニック、在宅ケアの現場が含まれ、在宅使用をサポートするウェアラブル技術の動向も高まっています。市場成長は、チューブレスやパッチポンプ、センサー技術の向上、リアルタイムモニタリングのためのスマートフォンアプリとの統合などの技術的進歩の影響を受けています。さらに、政府の支援ポリシーと償還シナリオは、市場の拡大において重要な役割を果たしています。糖尿病の有病率が上昇しているにもかかわらず、既存の医療インフラでは十分なサービスが提供されていない新興市場にも、大きなビジネス機会があります。このような機会を捉えるには、戦略的パートナーシップと地域密着型の市場アプローチを通じて、ユーザーフレンドリーなデザイン、手頃な価格、アクセスのしやすさに焦点を当てる必要があります。しかし、こうした医療機器には、多くの人々にとって高額となり得るコストや、機器の誤作動やソフトウェアのエラーといった技術的課題などの制約があります。さらに、承認や市場導入に関する規制上のハードルが、製品の入手を遅らせることもあります。競合情勢は急速な技術革新によって特徴付けられ、絶え間ない研究開発投資が必要となります。技術革新の最良のセグメントには、個別化治療のための人工知能主導型データ分析、人工膵臓システムとの統合、装着性と機能性を高めるための小型化と材料の進歩などがあります。市場の特性を理解するには、全人的な治療アプローチに焦点を当てた患者中心の医療へのシフトと、デジタルヘルス統合の重要性の高まりを認識することが必要であり、イノベーションの機は熟しているもの、戦略的管理が必要な課題が山積していることを示しています。

市場力学：急速に進化するインスリンポンプ市場の主要市場洞察を公開

インスリンポンプ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 糖尿病を患う高齢者の拡大
  • 糖尿病啓発のための医療資金と政府イニシアチブの増加
  • インスリン送達デバイスによる効率的な糖尿病管理に対する意識の高まり
• 市場抑制要因
  • インスリンポンプを適切に扱う熟練した専門家の不足
  • インスリンデバイスの高コスト
• 市場機会
  • 糖尿病治療機器における人工知能の登場
  • スマートインスリンポンプ技術の開発
• 市場課題
  • 皮膚感染やアレルギー反応、ケトアシドーシスのリスク

ポーターのファイブフォース：インスリンポンプ市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：インスリンポンプ市場における外部からの影響の把握

外部マクロ環境要因は、インスリンポンプ市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：インスリンポンプ市場における競合情勢の把握

インスリンポンプ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：インスリンポンプ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、インスリンポンプ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：インスリンポンプ市場における成功への道筋を描く

インスリンポンプ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 糖尿病を患う高齢者の増加
    • 糖尿病の認識を高めるための医療費助成と政府の取り組みの拡大
    • インスリン投与装置による効率的な糖尿病管理への意識の高まり
  • 抑制要因
    • インスリンポンプを適切に処理できる熟練した専門家の不足
    • インスリン装置の高コスト
  • 機会
    • 糖尿病ケア機器における人工知能の登場
    • スマートインスリンポンプ技術の開発
  • 課題
    • 皮膚感染症やアレルギー反応のリスク、ケトアシドーシスを患う患者
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 インスリンポンプ市場：製品別

• イントロダクション
• インスリンポンプ用品と付属品
• インスリンポンプ

第7章 インスリンポンプ市場：適応疾患別

• イントロダクション
• 1型糖尿病
• 2型糖尿病

第8章 インスリンポンプ市場：付属品別

• イントロダクション
• 輸液セット挿入器具
• 輸液セット
• インスリンリザーバー

第9章 インスリンポンプ市場：流通チャネル別

• イントロダクション
• 病院薬局
• 小売薬局
• 販売と糖尿病

第10章 南北アメリカのインスリンポンプ市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のインスリンポンプ市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのインスリンポンプ市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Animas Corporation
• Bayer AG
• Cellnovo Group SA.
• Cigna Corporation
• Dexcom Inc.
• F. Hoffmann-La Roche Ltd.
• Insulet Corporation
• Jiangsu Delfu Co. Ltd
• Medtronic
• Merck KGaA
• MicroPort Scientific Corporation
• Roche Diagnostics Corporation
• Sanofi SA
• Sensonic Corporation
• SOOIL Developments Co.
• Tandem Diabetes Care, Inc.
• Terumo Corporation
• Valeritas, Inc.
• Ypsomed AG

LIST OF FIGURES

• FIGURE 1. INSULIN PUMPS MARKET RESEARCH PROCESS
• FIGURE 2. INSULIN PUMPS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INSULIN PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES INSULIN PUMPS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES INSULIN PUMPS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. INSULIN PUMPS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. INSULIN PUMPS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INSULIN PUMPS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INSULIN PUMPS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INSULIN PUMPS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INSULIN PUMPS MARKET DYNAMICS
• TABLE 7. GLOBAL INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INSULIN PUMPS MARKET SIZE, BY INSULIN PUMP SUPPLIES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INSULIN PUMPS MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INSULIN PUMPS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INSULIN PUMPS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INSULIN PUMPS MARKET SIZE, BY INFUSION SET INSERTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INSULIN PUMPS MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INSULIN PUMPS MARKET SIZE, BY INSULIN RESERVOIRS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INSULIN PUMPS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INSULIN PUMPS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INSULIN PUMPS MARKET SIZE, BY SALES AND DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. CANADA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. CANADA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 37. CANADA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES INSULIN PUMPS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. CHINA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. CHINA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 58. CHINA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 59. CHINA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 60. INDIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. INDIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 63. INDIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA INSULIN PUMPS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. ITALY INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ITALY INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. ITALY INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 132. ITALY INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. POLAND INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. POLAND INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. POLAND INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 148. POLAND INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. QATAR INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. QATAR INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. QATAR INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 152. QATAR INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM INSULIN PUMPS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. INSULIN PUMPS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. INSULIN PUMPS MARKET, FPNV POSITIONING MATRIX, 2023

The Insulin Pumps Market was valued at USD 8.19 billion in 2023, expected to reach USD 9.08 billion in 2024, and is projected to grow at a CAGR of 10.97%, to USD 16.99 billion by 2030.

The insulin pump market is an essential segment of the diabetes management industry, focusing on providing continuous subcutaneous insulin infusion to help patients maintain glycemic control. The necessity arises from the increasing prevalence of diabetes worldwide, driven by lifestyle changes, obesity, and genetic factors. Its primary application is in managing type 1 diabetes, with growing use in type 2 cases where traditional insulin delivery methods prove inadequate. End-use scope primarily includes hospitals, specialty clinics, and home care settings, with a rising trend in wearable technologies supporting home usage. Market growth is influenced by technological advancements like tubeless and patch pumps, improved sensor technology, and integration with smartphone apps for real-time monitoring. Moreover, supportive government policies and reimbursement scenarios play a crucial role in expanding market reach. One significant opportunity lies within emerging markets where the prevalence of diabetes is escalating yet remains underserved by existing healthcare infrastructure. To seize these opportunities, businesses should focus on user-friendly designs, ensuring affordability and ease of access through strategic partnerships and localized market approaches. However, limitations include the high cost of these devices, which can be prohibitive for many, and technical challenges like device malfunction and software errors. Additionally, regulatory hurdles concerning approval and market introduction can delay product availability. The competitive landscape, marked by rapid innovations, necessitates constant R&D investment. Best areas for innovation include artificial intelligence-driven data analytics for personalized treatment, integration with artificial pancreas systems, and advancements in miniaturization and materials for enhanced wearability and functionality. Understanding market nature involves recognizing the shift towards patient-centered healthcare, focusing on holistic treatment approaches, and the increasing importance of digital health integration, signaling a landscape ripe for innovation yet fraught with challenges needing strategic management.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insulin Pumps Market

The Insulin Pumps Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expanding geriatric population with diabetes disease
  • Increasing healthcare funding and government initiatives to promote diabetes awareness
  • Growing awareness towards efficient diabetes management with insulin delivery devices
• Market Restraints
  • Lack of skilled professional for appropriate handling of insulin pumps
  • High cost of insulin devices
• Market Opportunities
  • Advent of artificial intelligence in diabetes care devices
  • Development of smart insulin pump technology
• Market Challenges
  • Risk of skin infection or allergic reaction and patient suffering from ketoacidosis

Porter's Five Forces: A Strategic Tool for Navigating the Insulin Pumps Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insulin Pumps Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insulin Pumps Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insulin Pumps Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insulin Pumps Market

A detailed market share analysis in the Insulin Pumps Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insulin Pumps Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insulin Pumps Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insulin Pumps Market

A strategic analysis of the Insulin Pumps Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insulin Pumps Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Animas Corporation, Bayer AG, Cellnovo Group SA., Cigna Corporation, Dexcom Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Jiangsu Delfu Co. Ltd, Medtronic, Merck KGaA, MicroPort Scientific Corporation, Roche Diagnostics Corporation, Sanofi SA, Sensonic Corporation, SOOIL Developments Co., Tandem Diabetes Care, Inc., Terumo Corporation, Valeritas, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Insulin Pumps Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Insulin Pump Supplies & Accessories and Insulin Pumps.
• Based on Disease Indication, market is studied across Type 1 Diabetes and Type 2 Diabetes.
• Based on Accessories, market is studied across Infusion Set Insertion Devices, Infusion Sets, and Insulin Reservoirs.
• Based on Distribution Channel, market is studied across Hospital Pharmacy, Retail Pharmacy, and Sales and Diabetes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expanding geriatric population with diabetes disease
    • 5.1.1.2. Increasing healthcare funding and government initiatives to promote diabetes awareness
    • 5.1.1.3. Growing awareness towards efficient diabetes management with insulin delivery devices
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of skilled professional for appropriate handling of insulin pumps
    • 5.1.2.2. High cost of insulin devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Advent of artificial intelligence in diabetes care devices
    • 5.1.3.2. Development of smart insulin pump technology
  • 5.1.4. Challenges
    • 5.1.4.1. Risk of skin infection or allergic reaction and patient suffering from ketoacidosis
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Insulin Pumps Market, by Product

• 6.1. Introduction
• 6.2. Insulin Pump Supplies & Accessories
• 6.3. Insulin Pumps

7. Insulin Pumps Market, by Disease Indication

• 7.1. Introduction
• 7.2. Type 1 Diabetes
• 7.3. Type 2 Diabetes

8. Insulin Pumps Market, by Accessories

• 8.1. Introduction
• 8.2. Infusion Set Insertion Devices
• 8.3. Infusion Sets
• 8.4. Insulin Reservoirs

9. Insulin Pumps Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospital Pharmacy
• 9.3. Retail Pharmacy
• 9.4. Sales and Diabetes

10. Americas Insulin Pumps Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Insulin Pumps Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Insulin Pumps Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Animas Corporation
• 3. Bayer AG
• 4. Cellnovo Group SA.
• 5. Cigna Corporation
• 6. Dexcom Inc.
• 7. F. Hoffmann-La Roche Ltd.
• 8. Insulet Corporation
• 9. Jiangsu Delfu Co. Ltd
• 10. Medtronic
• 11. Merck KGaA
• 12. MicroPort Scientific Corporation
• 13. Roche Diagnostics Corporation
• 14. Sanofi SA
• 15. Sensonic Corporation
• 16. SOOIL Developments Co.
• 17. Tandem Diabetes Care, Inc.
• 18. Terumo Corporation
• 19. Valeritas, Inc.
• 20. Ypsomed AG